Health & Medicine : Science World Report

Feb 21, 2012 03:26 PM EST

New Blood Test for Early Cancer Detection Developed by Ben-Gurion University Researchers

A simple blood test is being developed by researchers at Ben-Gurion University of the Negev (BGU) and Soroka University Medical Center in Beer-Sheva, Israel that may provide early detection of many types of cancer.

Feb 21, 2012 01:34 PM EST

Mapping of Protein Inhibitors Facilitates Development of Tailor-made Anticancer Agents

A team of researchers at Karolinska Institutet in Sweden has generated a map over the effects of small drug-like molecules on PARP1 and other similar proteins in the body. This map may explain the mechanism behind putative side effects of the so-called PARP inhibitors, and can play an important role...

Feb 21, 2012 01:20 PM EST

EARTH: Gold, Lead and Death in Nigeria

Throughout the Zamfara region in northwestern Nigeria, children are dying at an alarming rate. What exactly could be causing such an epidemic? The answer lies in the unique geology. Lead-rich gold ores permeate the area, and mining them provides critical income for many families in need. Families ge...

Feb 21, 2012 12:49 PM EST

Tongue Drive System Goes Inside the Mouth to Improve Performance and User Comfort

The Tongue Drive System is getting less conspicuous and more capable. Tongue Drive is a wireless device that enables people with high-level spinal cord injuries to operate a computer and maneuver an electrically powered wheelchair simply by moving their tongues.

Feb 21, 2012 10:44 AM EST

Traitorous Immune Cells Promote sudden Ovarian Cancer Progression

Aggressive ovarian tumors begin as malignant cells kept in check by the immune system until, suddenly and unpredictably, they explode into metastatic cancer. New findings from scientists at The Wistar Institute demonstrate that ovarian tumors don't necessarily break "free" of the immune system, rath...

Feb 21, 2012 09:57 AM EST

Benefits of Hepatitis C Treatment Outweigh Costs for Patients with Advanced Disease

A towering $60,000 bill, a year of fierce, flu-like symptoms and a running risk of depression are among the possible costs of two new hepatitis C treatments. But according to Stanford University health policy researchers, they might be worth it.

Feb 21, 2012 09:44 AM EST

Guideline: Monitoring spinal cord during surgery may help prevent paralysis

The American Academy of Neurology is issuing an updated guideline that recommends monitoring the spinal cord during spinal surgery and certain chest surgeries to help prevent paralysis, or loss of muscle function, related to the surgeries.

Feb 21, 2012 09:00 AM EST

Embargoed News for Annals of Internal Medicine

Approximately 3.2 million people in the United States are infected with chronic hepatitis C virus (HCV), a leading cause of liver disease, cirrhosis, and death. Chronic hepatitis infection is most prevalent among people born from 1945 through 1965, and most of them do not know they are infected. Thi...

Feb 21, 2012 07:41 AM EST

Mother's Migraine may Increase Baby's Risk of Colic

New research suggests that mothers who experience migraine may be more likely to have a baby with colic than mothers without a history of migraine. Colic is defined as excessive crying in an otherwise healthy infant. The research was released today and will be presented at the American Academy of Ne...

Feb 20, 2012 06:08 PM EST

Rainforest Plant Combats Multi-resistant Bacterial Strains

Aggressive infections in hospitals are an increasing health problem worldwide. The development of bacterial resistance is alarming. Now a young Danish scientist has found a natural substance in a Chilean rainforest plant that effectively supports the effect of traditional treatment with antibiotics.

Feb 20, 2012 03:44 PM EST

Director Discusses Cancer Evolution at Prestigious Conference

Professor Mike Stratton will speak at the 2012 AAAS annual meeting about the evolution of the cancer genome

Feb 20, 2012 02:03 PM EST

The USP15 Biological Thermostat: A Promising Novel Therapeutic Target in Cancer

After years studying the molecular bases of glioblastoma - the most common brain tumor and one of the most aggressive of all cancers, the group led by Dr. Joan Seoane , Director of Translational Research at the Vall d'Hebron Institute of Oncology (VHIO) and ICREA Research Professor has today publish...